OR-101

N/A

Report date: 2024/04/06 20:00:41
NME

Base Information

Drug NameOR-101
Drug Alias NameOR-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitorsTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase JAK3Tyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsAlopecia AreataDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrnovi Inc
China Registration ClassN/A

Develop Information

Active CompaniesOrnovi Inc
Inactive CompaniesN/A
Active IndicationsDermatitis
Inactive IndicationsAlopecia Areata

Other Information

ATC CodeN/A
Related LinksN/A